Cited by 743NF-κB Signaling PathwaysNatural Compounds in Disease TreatmentSignaling Pathways in Disease

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B

Open access

Wahl, C, Liptay, S, Adler, G, Schmid, R M·1998·Journal of Clinical Investigation

Open this paper in CoChat — free account

Abstract

Transcription factors of the NF-kappaB/Rel family are critical for inducible expression of multiple genes involved in inflammatory responses. Sulfasalazine and its salicylate moiety 5-aminosalicylic acid are among the most effective agents for treating inflammatory bowel disease and rheumatoid arthritis. However, the mode of action of these drugs remains unclear. Here we provide evidence that the transcription factor NF-kappaB is a target of sulfasalazine-mediated immunosuppression. Treatment of SW620 colon cells with sulfasalazine inhibited TNFalpha-, LPS-, or phorbol ester- induced NF-kappaB activation. NF-kappaB-dependent transcription was inhibited by sulfasalazine at micro- to millimolar concentrations. In contrast, 5-aminosalicylic acid or sulfapyridine did not block NF-kappaB activation at all doses tested. TNFalpha-induced nuclear translocation of NF-kappaB was prevented by sulfasalazine through inhibition of IkappaBalpha degradation. When blocking proteasome-mediated degradation of IkappaBalpha, we could demonstrate that sulfasalazine interfered with IkappaBalpha phosphorylation, suggesting a direct effect on an IkappaBalpha kinase or on an upstream signal. Inhibition of NF-kappaB activation seems to be specific since other DNA-binding activities such as AP1 were not affected. These results demonstrate that sulfasalazine is a potent and specific inhibitor of NF-kappaB activation, and thus may explain some of the known biological properties of sulfasalazine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci992

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.
Schreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,793
NF-κB: Ten Years After
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,002
Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,089
Structure, Regulation and Function of NF-kappaB
Siebenlist, U. K., Franzoso, G., & Brown, K. D. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,086
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E. B., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,744
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,676
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434

Show all 48 references

Research works printed but not linked: 1

[34]34. Chiao, P.J., M. Shigeki, and I.M. Verma. 1994. Autoregulation of I k B a activity. Proc. Natl. Acad. Sci. USA. 91:28-32.

Sorted by citations

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Inflammation and Colon Cancer
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,593
The IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364
Series Introduction: The transcription factor NF-κB and human disease
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11891 · Cited by 990
The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
Lewerenz, J., Hewett, S. J., Huang, Y. S., Lambros, M. P., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I. J., Methner, A., Pergande, M., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 1,021
Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
Maeda, S., Hsu, L.-C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., & Karin, M. (2005) · Science · doi:10.1126/science.1103685 · Cited by 748
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1588 · Cited by 720
Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
Hanai, H., Iida, T., Takeuchi, K., Watanabe, F., Maruyama, Y., Andoh, A., Tsujikawa, T., Fujiyama, Y., Mitsuyama, K., Sata, M., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.08.008 · Cited by 704
Interferon-γ and Tumor Necrosis Factor-α Synergize to Induce Intestinal Epithelial Barrier Dysfunction by Up-Regulating Myosin Light Chain Kinase Expression
Wang, F., Graham, W. V., Wang, Y., Witkowski, E. D., Schwarz, B. T., & Turner, J. R. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62264-x · Cited by 692
NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis
Roman‐Blas, J. A., & Jiménez, S. A. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.04.008 · Cited by 701
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug
Gout, P., Buckley, A., Simms, C., & Bruchovsky, N. (2001) · Leukemia · doi:10.1038/sj.leu.2402238 · Cited by 640
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
Su, Y., Zhao, B., Zhou, L., Zhang, Z., Shen, Y., Lv, H., AlQudsy, L. H. H., & Shang, P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.015 · Cited by 586
Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis
Chang, L.-C., Chiang, S.-K., Chen, S.-E., Yu, Y.-L., Chou, R.-H., & Chang, W.-C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.12.025 · Cited by 521
The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line
Inan, M. S., Rasoulpour, R. J., Yin, L., Hubbard, A. K., Rosenberg, D. W., & Giardina, C. A. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70142-9 · Cited by 502
The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
Hebbel, R. P., Osarogiagbon, R. U., & Kaul, D. K. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 464
17β-Estradiol Inhibits Inflammatory Gene Expression by Controlling NF-κB Intracellular Localization
Ghisletti, S., Meda, C., Maggi, A. C., & Vegeto, E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.2957-2968.2005 · Cited by 472
Treatment of inflammatory bowel disease (IBD)
Pithadia, A. B., & Jain, S. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70575-8 · Cited by 439
Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy
Jiang, Q., Wang, K., Zhang, X., Ouyang, B., Liu, H., Pang, Z., & Yang, W. (2020) · Small · doi:10.1002/smll.202001704 · Cited by 426
Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)
Hammarström, L. L. G., Vořechovský, I., & Webster, D. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01131.x · Cited by 420
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
Chen, L., Rong, D., Zhang, B., Zheng, W., Wang, X., Chen, Z., & Tang, W. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1047-6 · Cited by 419
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
Elsharkawy, A. M., Oakley, F., & Mann, D. A. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1055-4 · Cited by 421
The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer
Greten, F. R. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.08.029 · Cited by 410
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
Lo, M., Wang, Y., & Gout, P. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21366 · Cited by 399
Lipopolysaccharide Induces Rac1-dependent Reactive Oxygen Species Formation and Coordinates Tumor Necrosis Factor-α Secretion through IKK Regulation of NF-κB
Sanlioglu, S., Williams, C. M., Samavati, L., Butler, N. S., Wang, G., McCray, P. B., Ritchie, T. C., Hunninghake, G. W., Zandi, E., & Engelhardt, J. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102061200 · Cited by 395
The IκB/NF-κB system: a key determinant of mucosal inflammation and protection
Jobin, C., & Sartor, R. B. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.3.c451 · Cited by 382
Expression and function of Toll-like receptors 2 and 4 in human keratinocytes
Pivarcsi, A. (2003) · International Immunology · doi:10.1093/intimm/dxg068 · Cited by 352
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
Li, P., Zheng, Y., & Chen, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00460 · Cited by 354
Role of NF-κB in immune and inflammatory responses in the gut
Neurath, M. F., Becker, C., & Barbulescu, K. (1998) · Gut · doi:10.1136/gut.43.6.856 · Cited by 349
Nuclear Factor Kappa B Regulation of Proinflammatory Cytokines in Human Gestational Tissues In Vitro1
Lappas, M., Permezel, M., Georgiou, H. M., & Rice, G. E. (2002) · Biology of Reproduction · doi:10.1095/biolreprod67.2.668 · Cited by 345
Biologic therapy of inflammatory bowel disease
Sandborn, W. J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.33426 · Cited by 341
Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia
Vilimas, T., Mascarenhas, J., Palomero, T., Mandal, M., Buonamici, S., Meng, F., Thompson, B. J., Spaulding, C., Macaroun, S., Alegre, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1524 · Cited by 335
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis
Karban, A. S., Okazaki, T., Panhuysen, C. I. M., Gallegos, T. F., Potter, J. J., Wilson, J., Silverberg, M. S., Duerr, R. H., Cho, J. H., Gregersen, P. K., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh008 · Cited by 340
NF-κB signaling, liver disease and hepatoprotective agents
Sun, B., & Karin, M. (2008) · Oncogene · doi:10.1038/onc.2008.300 · Cited by 307
Pathophysiology and treatment of stroke in sickle-cell disease: present and future
Switzer, J. A., Hess, D. C., Nichols, F. T., & Adams, R. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70469-0 · Cited by 315
The Role of Iron Regulation in Immunometabolism and Immune-Related Disease
Cronin, S. J. F., Woolf, C. J., Weiss, G., & Penninger, J. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00116 · Cited by 299
Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β
Weber, C. K., Liptay, S., Wirth, T., Adler, G., & Schmid, R. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19458 · Cited by 298
Self-citation
Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course
Schirmer, M., Denson, L. A., Vlamakis, H. C., Franzosa, E. A., Thomas, S., Gotman, N., Rufo, P. A., Baker, S. S., Sauer, C. G., Markowitz, J. F., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.09.009 · Cited by 292
Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy
Alam, J., Jantan, I., & Bukhari, S. N. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.055 · Cited by 286
Therapeutic effect of intracolonically administered nuclear factor κ B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis
Murano, M., Maemura, K., Hirata, I., Toshina, K., Nishikawa, T., Hamamoto, N., Sasaki, S., Saitoh, O., & Katsu, K. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01183.x · Cited by 281
Oxidative stress in ulcerative colitis-associated carcinogenesis
Roessner, A., Kuester, D., Malfertheiner, P., & Schneider-Stock, R. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.04.011 · Cited by 270
Mechanisms of testicular torsion and potential protective agents
Karagüzel, E., Kadıhasanoğlu, M., & Kutlu, Ö. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.135 · Cited by 267
Inhibition of inhibitor of κB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis
Oakley, F., Meso, M., Iredale, J. P., Green, K., Marek, C. J., Zhou, X., May, M. J., Millward‐Sadler, H., Wright, M. C., & Mann, D. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.003 · Cited by 265
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in mice
Sugimoto, K., Hanai, H., Tozawa, K., Aoshi, T., Uchijima, M., Nagata, T., & Koide, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.37050 · Cited by 262
NRF2, a Superstar of Ferroptosis
Yan, R., Lin, B., Jin, W., Tang, L., Hu, S., & Cai, R. (2023) · Antioxidants · doi:10.3390/antiox12091739 · Cited by 292
NF-κB/Rel activation in cerulein pancreatitis
Steinle, A. U., Weidenbach, H., Wagner, M., Adler, G., & Schmid, R. M. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70140-x · Cited by 254
Self-citation
The Transcription Factor Nuclear Factor-kappa B and Cancer
Escarcega, R. O., Fuentes-Alexandro, S. A., García‐Carrasco, M., Gatica, A., & Zamora, A. (2007) · Clinical Oncology · doi:10.1016/j.clon.2006.11.013 · Cited by 240
The IκB Kinase Regulates Chromatin Structure during Reconsolidation of Conditioned Fear Memories
Lubin, F. D., & Sweatt, J. D. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.039 · Cited by 241
Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor κB activation in mouse colonocytes
Kaiser, G. C., Yan, F., & Polk, D. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70182-4 · Cited by 234
Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF‐κB
Riehemann, K., Behnke, B., & Schulze‐Osthoff, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01622-6 · Cited by 230
Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin
Arlt, A., Vorndamm, J., Breitenbroich, M., Fölsch, U. R., Kalthoff, H., Schmidt, W. E., & Schäfer, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204168 · Cited by 227
Thiol-Reactive Metal Compounds Inhibit NF-κB Activation by Blocking IκB Kinase
Jeon, K., Jeong, J.-Y., & Jue, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5981 · Cited by 226
Inhibition of Interleukin-1-stimulated NF-κB RelA/p65 Phosphorylation by Mesalamine Is Accompanied by Decreased Transcriptional Activity
Egan, L. J., Mays, D. C., Huntoon, C. J., Bell, M. P., Pike, M. G., Sandborn, W. J., Lipsky, J. J., & McKEAN, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26448 · Cited by 217
Current management of inflammatory bowel disease and colorectal cancer.
Mattar, M. C., Lough, D., Pishvaian, M. J., & Charabaty, A. (2011) · Europe PMC (PubMed Central) · Cited by 214
Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway
Epinat, J.-C., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203218 · Cited by 204
Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models
Oz, H. S., Chen, T., & de Villiers, W. J. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00132 · Cited by 206
Cutaneous lupus erythematosus: Update of therapeutic options
Kuhn, A., Ruland, V., & Bonsmann, G. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.06.018 · Cited by 200
Mesalazine Inhibits Activation of Transcription Factor Nf-κB in Inflamed Mucosa of Patients With Ulcerative Colitis
Bantel, H., Berg, C. P., Vieth, M., Stolte, M., Kruis, W., & Schulze‐Osthoff, K. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03360.x · Cited by 200
Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis
Neidhart, M., Wehrli, R., Br�hlmann, P., Michel, B. A., Gay, R. E., & Gay, S. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4 · Cited by 82
Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis — A randomized, placebo-controlled, pilot study
Singla, V., Mouli, V. P., Garg, S. K., Rai, T., Choudhury, B. N., Verma, P., Deb, R., Tiwari, V., Rohatgi, S., Dhingra, R., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.08.006 · Cited by 195
Curcumin attenuates DNB-induced murine colitis
Salh, B., Assi, K., Templeman, V., Parhar, K. K. S., Owen, D., Gómez‐Muñoz, A., & Jacobson, K. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00449.2002 · Cited by 193
A role for transcription factor NF- k B in intestinal inflammation
Schottelius, A. J. G., & Baldwin, A. S. (1999) · International Journal of Colorectal Disease · doi:10.1007/s003840050178 · Cited by 189
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
Robe, P. A. J. T., Martin, D., Nguyen-Khac, M., Artesi, M., Deprez, M., Albert, A., Vanbelle, S., Califice, S., Bredel, M., & Bours, V. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-372 · Cited by 184
NFκB: a promising target for natural products in cancer chemoprevention
Luqman, S., & Pezzuto, J. M. (2010) · Phytotherapy Research · doi:10.1002/ptr.3171 · Cited by 187
Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB
Cronstein, B. N., Montesinos, M. C., & Weissmann, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6377 · Cited by 183
The Melanocortin System in Control of Inflammation
Catania, A., Lonati, C., Sordi, A., Carlin, A., Leonardi, P., & Gatti, S. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.173 · Cited by 181
Tumor Necrosis Factor-α Causes Accumulation of a Ubiquitinated Form of Hypoxia Inducible Factor-1α through a Nuclear Factor-κB-Dependent Pathway
Zhou, J., Schmid, T., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0598 · Cited by 177
Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy
Zheng, L., Howell, S. J., Hatala, D. A., Huang, K., & Kern, T. S. (2007) · Diabetes · doi:10.2337/db06-0789 · Cited by 175
Cancer-associated fibroblasts in hepatocellular carcinoma
Kubo, N., Araki, K., Kuwano, H., & Shirabe, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6841 · Cited by 177
Nuclear factor-κB as a therapeutic target in critical care medicine
Zingarelli, B., Sheehan, M., & Wong, H. R. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301001-00015 · Cited by 174
Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancer
Liptay, S., Weber, C. K., Ludwig, L., Wagner, M., Adler, G., & Schmid, R. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11081 · Cited by 172
Self-citation
Cystine–glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity
Arensman, M. D., Yang, X. S., Leahy, D., Toral‐Barza, L., Mileski, M., Rosfjord, E. C., Wang, F., Deng, S., Myers, J. S., Abraham, R. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814932116 · Cited by 171
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
Stein, R. B., & Hanauer, S. B. (2000) · Drug Safety · doi:10.2165/00002018-200023050-00006 · Cited by 169
The Human Tumor Necrosis Factor (TNF) Receptor-associated Factor 1 Gene (TRAF1) Is Up-regulated by Cytokines of the TNF Ligand Family and Modulates TNF-induced Activation of NF-κB and c-Jun N-terminal Kinase
Schwenzer, R., Siemienski, K., Liptay, S., Schubert, G., Peters, N., Scheurich, P., Schmid, R. M., & Wajant, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19368 · Cited by 168
Self-citation
Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles
Mladenovska, K., Raichki, R. S., Janevik-Ivanovska, E., Ristoski, T., Pavlova, M. J., Kavrakovski, Z., Dodov, M. G., & Goračinova, K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.028 · Cited by 165
Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
Boer, M. M. B.-D., van Wetten, M.-L., & Pruimboom, L. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-32 · Cited by 172
INHIBITION OF TNF-α AND IL-6 PRODUCTION BY AUCUBIN THROUGH BLOCKADE OF NF-κB ACTIVATION IN RBL-2H3 MAST CELLS
Jeong, H., Koo, H., Na, H.-J., Kim, M.-S., Hong, S., Eom, J.-W., Kim, K., Shin, T., & Kim, H. (2002) · Cytokine · doi:10.1006/cyto.2002.0894 · Cited by 161
Glutathione and its precursors in cancer
Asantewaa, G., & Harris, I. S. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.03.001 · Cited by 160
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Shams, S., Martinez, J. M., Dawson, J. R. D., Flores, J. C., Gabriel, M., Garcia, G., de Guevara, A. L., Murray, K. M., Pacifici, N. J., Vargas, M. V., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680043 · Cited by 162
Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity
Herrington, F., Carmody, R. J., & Goodyear, C. S. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115617456 · Cited by 156
The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis
Sadeghi, N., Mansoori, A., Shayesteh, A., & Hashemi, S. J. (2019) · Phytotherapy Research · doi:10.1002/ptr.6581 · Cited by 151
Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling
Eyre, R., Alférez, D., Santiago-Gómez, A., Spence, K., McConnell, J. C., Hart, C. A., Simões, B. M., Lefley, D. V., Tulotta, C., Storer, J. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12807-0 · Cited by 150
Modulation of endothelial cell activation in sickle cell disease: a pilot study
Solovey, A., Solovey, A. N., Harkness, J., & Hebbel, R. P. (2001) · Blood · doi:10.1182/blood.v97.7.1937 · Cited by 148
NF-κB in cancer—a friend turned foe
Ravi, R. K. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.003 · Cited by 147
The Serine/Threonine Phosphatase, PP2A: Endogenous Regulator of Inflammatory Cell Signaling
Shanley, T. P., Vasi, N., Denenberg, A. G., & Wong, H. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.966 · Cited by 146
The Role of Nuclear Factor κB in Tumor Necrosis Factor-Regulated Transcription of the Human μ-Opioid Receptor Gene
Kraus, J., Börner, C., Giannini, E., & Höllt, V. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.876 · Cited by 146
Betulinic acid as new activator of NF-κB: molecular mechanisms and implications for cancer therapy
Kasperczyk, H., Ferla-Brühl, K. L., Westhoff, M., Behrend, L., Zwacka, R. M., Debatin, K., & Fulda, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208842 · Cited by 145
Bcl-2 Activates the Transcription Factor NFκB through the Degradation of the Cytoplasmic Inhibitor IκBα
de Moissac, D., Mustapha, S., Greenberg, A. H., & Kirshenbaum, L. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23946 · Cited by 145
NF-κB/Rel/IκB: Implications in gastrointestinal diseases
Schmid, R. M., & Adler, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70374-x · Cited by 139
Self-citation
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
Ceccarelli, S., Panera, N., Mina, M., Gnani, D., Stefanis, C. D., Crudele, A., Rychlicki, C., Petrini, S., Bruscalupi, G., Agostinelli, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5163 · Cited by 141
Targeting the NF-κB Pathway in Cancer Therapy
Erstad, D. J., & Cusack, J. C. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.011 · Cited by 143
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition
Sharbeen, G., McCarroll, J. A., Akerman, A., Kopecky, C., Youkhana, J., Kokkinos, J., Holst, J., Boyer, C. A., Erkan, M., Goldstein, D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2496 · Cited by 135
The x c − cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine
Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C. M., Buckley, A. R., Lam, S., Gout, P. W., & Wang, Y.-Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0894-4 · Cited by 134
Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema
Sehm, T., Fan, Z., Ghoochani, A., Rauh, M., Engelhorn, T., Minakaki, G., Dörfler, A., Klucken, J., Buchfelder, M., Eyüpoglu, I. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8651 · Cited by 134
Inhibitory kappa B kinases as targets for pharmacological regulation
Gamble, C., McIntosh, K., Scott, R., Ho, K. H., Plevin, R. J., & Paul, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01608.x · Cited by 134
Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages
Kim, H., Kim, W.-J., Jeon, S., Koh, E., Cha, H., Ahn, K., & Lee, W. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.05.004 · Cited by 131
Inhibition of NF‐ κ B and AP‐1 activation by R‐ and S‐flurbiprofen 1 2
Tegeder, I., Niederberger, E., ISRAR, E., Gühring, H., Brune, K., Euchenhofer, C., Grösch, S., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fasebj.15.3.595 · Cited by 130
Cutting Edge: The IκB Kinase (IKK) Inhibitor, NEMO-Binding Domain Peptide, Blocks Inflammatory Injury in Murine Colitis
Shibata, W., Maeda, S., Hikiba, Y., Yanai, A., Ohmae, T., Sakamoto, K., Nakagawa, H., Ogura, K., & Omata, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2681 · Cited by 130
Current Immunotherapy in Rheumatoid Arthritis
Meier, F. M. P., Frerix, M., Hermann, W., & Müller‐Ladner, U. (2013) · Immunotherapy · doi:10.2217/imt.13.94 · Cited by 135

Authors: Wahl, C., Liptay, S., Adler, G., & Schmid, R. M.
Affiliations: Universität Ulm (DE)
Corresponding author: Schmid, R M
ORCID: Schmid, R M
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1998-03-01
Volume: 101
Issue: 5
Pages: 1163-1174
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci992
PMC: PMC508669
OpenAlex: W2011496352
Cited by: 742
References: 48
Citations by year: 2026: 13 · 2025: 16 · 2024: 17 · 2023: 18 · 2022: 18 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 19 · 2017: 11 · 2016: 15 · 2015: 19 · 2014: 17 · 2013: 24 · 2012: 19
FWCI: 17.22
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords: sulfasalazine, NF-κB, IκBα degradation, IκBα phosphorylation, IκBα kinase, NF-κB nuclear translocation, 5-aminosalicylic acid, sulfapyridine, TNF-α, LPS, phorbol ester, proteasome, AP-1, immunosuppression, inflammatory bowel disease, rheumatoid arthritis, colon cancer cells
MeSH terms: Anti-Infective Agents, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Aspirin, Cells, Cultured, Colonic Diseases, Cystine, Epithelial Cells, Humans, Immunosuppression Therapy, Lipopolysaccharides, Phorbol Esters, Phosphorylation, Plasmids, Proline, Recombinant Proteins, Recombination, Genetic, Sulfasalazine, Sulfapyridine, Thiocarbamates, Transfection, Tumor Necrosis Factor-alpha, Blotting, Western, NF-kappa B, Transcription Factor AP-1, Fluorescent Antibody Technique, Indirect, Mesalamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks